RGA has created an online digital platform featuring an in-depth analysis of US population mortality in the wake of COVID-19. As a central component of that analysis, RGA's Global R&D team produced a report on all-cause excess mortality, which is summarized below.
In the wake of the COVID-19 pandemic, RGA has conducted a thorough analysis of emerging US population data to explore how all-cause mortality and excess mortality have changed through the pandemic, determine what they look like in the short term, and understand where they may be headed.
While we have observed persistent excess mortality in the US population following the acute phase of the COVID-19 pandemic, recent mortality trends – including 2024 excess death estimates – suggest that the overall excess has decreased substantially from the peak of the acute phase. Indeed, there is a possibility that the age-standardized mortality – for some age groups and sometimes depending on sex – will be lower in 2024 overall than that observed in 2019 and in-line with pre-pandemic expectations for the period.
To understand where population excess mortality may be headed in the medium term, a comprehensive evaluation of each major cause of death is essential. RGA will examine some of the trends in specific causes in subsequent reports.
To learn about the latest all-cause and by-cause report updates as they are published, sign up for RGA’s US mortality analysis email list.
